(EMAILWIRE.COM, April 21, 2017 ) Browse 87 market data tables and 65 figures spread through 176 pages and in-depth TOC on “PEGylated Proteins Market”
http://www.marketsandmarkets.com/Market-Reports/pegylated-protein-market-19242378.html
Early buyers will receive 10% customization on this report.

PEGylation of therapeutic proteins is becoming increasingly essential because of PEG's ability to protect against protein enzymatic degradation and increasing half-life of drugs.

Industry Dynamics:

Increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing in adoption of protein based drugs over non-protein based drugs and increase of protein stability and circulating half-life with the help of PEGylation are the major drivers of market. On the other hand drug failure and recalls is the major factor restraining the growth of this market.

Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=19242378

Geographical Analysis:

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW). The report maps each product, protein type, application and end-user segment in 6 geographic and regional segments. Geographic analysis reveals that North America accounted for the largest share of the global PEGylated proteins market in 2016.

Growth in this market can be attributed to the increased adoption of biologics drugs such as monoclonal antibodies, erythropoietin and interferon for the treatment of chronic diseases; increasing government funding and grants for research activities, and increasing R&D spending for drug discovery at early stages.

Inquire More about This Report@
http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=19242378

Similarly Asia is estimated to be the fastest growing market of the global market in 2016. The wide applications of PEGylated proteins in treating cancer, blood disorder, chronic and autoimmune disease are expected to drive the demand for market in this region.

Prominent Industry Leaders:

The major players in this market include Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), NOF Corporation (Japan), JenKem Technology USA, Inc. (U.S.), Creative PEGworks (U.S), Celares GmbH (Germany), Quanta BioDesign, Ltd. (U.S.), Biomatrik, Inc, (China), Iris Biotech GmbH (Germany), Laysan Bio, Ltd. (U.S.).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441